Overview
Shoeb Jendi practices practicing medicine in Ratnagiri, India.
Their clinical expertise encompasses Optic Glioma, Fibromatosis, Oral Cancer, and Neurofibromatosis Type 1 (NF1).
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shoeb K. Jendi
Is Shoeb K. Jendi a top-rated expert for Optic Glioma?
MediFind is an objective health platform that identifies experts based on real-world data. Shoeb K. Jendi is classified as an Experienced expert for Optic Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shoeb K. Jendi participate in research or clinical trials?
Yes. Shoeb K. Jendi has published 8 articles and abstracts on conditions like Optic Glioma. You can view a list of Shoeb K. Jendi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- FibromatosisJendi isExperienced. Learn about Fibromatosis.
- NeurofibromatosisJendi isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)
- Optic GliomaJendi isExperienced. Learn about Optic Glioma.
- Oral CancerJendi isExperienced. Learn about Oral Cancer.